Feedback / Questions
Gazyva (obinutuzumab) - Roche, Biogen
Gazyva: Regulatory approval in EU for SLE in 2027
(Roche)
-
Oct 1, 2026 -
Pharma Day 2026: Regulatory approval in EU for membranous nephropathy in 2027
EMA approval
•
Immunology • Lupus • Systemic Lupus Erythematosus
https://assets.roche.com/f/176343/x/51deda2587/20260928_final_pharma-day-2026-publish-1.pdf
Oct 1, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next